Workflow
Vertex (VRTX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
VRTXVertex(VRTX) ZACKS·2024-11-06 00:30

Vertex Pharmaceuticals (VRTX) reported 2.77billioninrevenueforthequarterendedSeptember2024,representingayear−over−yearincreaseof11.62.77 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 11.6%. EPS of 4.38 for the same period compares to 4.08ayearago.Thereportedrevenuerepresentsasurpriseof+3.624.08 a year ago.The reported revenue represents a surprise of +3.62% over the Zacks Consensus Estimate of 2.67 billion. With the consensus EPS estimate being $4.13, the EPS surprise was +6.05%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare ...